← Back
▼ SELL 10b5-1 Plan

$ Value

$284K

Shares

9,000

Price

$32

Filed

Oct 15

Insider

Name

Hopkinson Craig C.

Title

EVP R&D, Chief Medical Officer

CIK

0001730048

Roles

Officer

Transaction Details

Transaction Date

2025-10-15

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

73,740

Footnotes

This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/14/2025. | This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/14/2025. | The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $31.51 to $31.60. Full information regarding the number of shares sold at each separate price can be provided to the issuer, any security holder of the issuer or the SEC staff upon request. | These options are fully vested in accordance with their terms.

Filing Info

Accession No.

0001520262-25-000008

Form Type

4

Issuer CIK

0001520262

Hopkinson Craig C.'s History

Date Ticker Type Value
2026-04-01 ALKS M $97K
2026-04-01 ALKS $320K
2026-04-01 ALKS M $0
2025-12-03 ALKS M $72K
2025-12-03 ALKS $112K
2025-12-03 ALKS M $0
2025-12-01 ALKS $117K
2025-11-03 ALKS M $97K
2025-11-03 ALKS $273K
2025-11-03 ALKS M $0

Other Insiders at ALKS (90d)

Insider Bought Sold Last
Lurker Nancy 2026-04-11
Gaffin David Joseph
EVP, CLO, Alkermes, Inc.
$70K 2026-04-06
Hopkinson Craig C.
EVP R&D, Chief Medical Officer
$320K 2026-04-01